跳至主要内容
临床试验/NCT02409511
NCT02409511Unknown不适用

Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)

Hospital Universitari Vall d'Hebron Research Institute1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
75
试验地点
1
主要终点
To find markers for a better definition of the meaning of microalbuminuria

研究概览

简要总结

Microalbuminuria (MA) is an independent cardiovascular risk factor in diabetic and non-diabetic subjects.

However, in the setting of type 2 diabetes, microalbuminuria could be a marker of either early diabetic nephropathy or diffuse endothelial dysfunction. At present, there are no biomarkers that permit us to discriminate between these two conditions.

详细描述

A hypothesis free approach by using proteomic/metabolomic analyses in the urine samples of selected populations seems an appropriate approach by which to explore this issue. In addition, a driven hypothesis in the same groups of patients based on a sensitive marker of kidney injury also seems appropriate.

Urinary levels of KIM-1(Kidney Injury Molecule-1 ) have been found elevated in experimental diabetic nephropathy even before that MA . In addition, urinary levels of KIM-1 were found significantly elevated in type 1 diabetic patients with MA, in comparison with diabetics with normoalbuminuria and non-diabetic healthy controls. Moreover, low urinary KIM-1 levels at baseline were associated with the regression of MA during a follow-up of 2 years . Therefore, it could be hypothesized that the presence of MA + KIM-1 in urine samples would indicate renal injury rather than endothelial dysfunction.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with diabetes mellitus type 2 with microalbuminuria with and without retinopathy.
  • Control groups: diabetes mellitus type 1 with microalbuminuria and retinopathy hypertensive patients with microalbuminuria and diabetic patients with a renal biopsy

排除标准

  • Patients without microalbuminuria or patients with macroalbuminuria

结局指标

主要结局

To find markers for a better definition of the meaning of microalbuminuria

时间窗: 3 years

Improve diagnosis of diabetic nephropathy

Complementary markers for improving the performance of MA

时间窗: 3 years

Improve diagnosis of diabetic nephropathy

次要结局

  • To identify candidates which could help to discriminate whether microalbuminuria is related to endothelial dysfunction rather than kidney damage(3 years)
  • To test whether the enhancement of this specific marker of kidney injury is able to identify those patients in which MA really means diabetic nephropathy.(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验